Evolus (EOLS) EBIT Margin (2019 - 2026)

Evolus (EOLS) reported EBIT Margin of 9.36% for Q1 2026, up 1278.0% on a YoY basis from 0.68% in Q1 2025, and down 300.36% quarter-over-quarter from 4.67% in Q4 2025.

Evolus (EOLS) EBIT Margin (2019 - 2026) Analysis & Trends

Evolus has reported EBIT Margin for 8 years, with the latest figure at 9.36% in Q1 2026.

  • For the quarter ending Q1 2026, EBIT Margin rose 1278.0% year-over-year to 9.36%; the trailing twelve-month figure through Mar 2026 stood at 8.06% (up 670.0% YoY), and the FY2025 full-year result was 10.99%, up 193.0% from the prior year.
  • EBIT Margin for Q1 2026 stood at 9.36%, down from 4.67% in the prior quarter.
  • The five-year high for EBIT Margin was 4.67% in Q4 2025, with the low at 57.44% in Q2 2022.
  • Historically, EBIT Margin has averaged 23.16% across 5 years, with a median of 22.14% in 2025.
  • The largest YoY upside for EBIT Margin was 2765 bps in 2022 against a maximum downside of 11113 bps in 2022.
  • Evolus' EBIT Margin stood at 24.37% in 2022, then surged by 42 bps to 14.16% in 2023, then jumped by 79 bps to 2.93% in 2024, then jumped by 259 bps to 4.67% in 2025, then sank by 300 bps to 9.36% in 2026.
  • The last three EBIT Margin figures came in at 9.36% (Q1 2026), 4.67% (Q4 2025), and 16.67% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 16.37%
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 36.83%
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 41.69%
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 20.77%
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 23.74%
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 22.39%
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -122.23%
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 21.55%
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn -12.88%
10 Evolus 435.45 Mn 385.65 Mn 48.90 Mn -9.36%

Historic Data

Download Data
DateValue
Mar 31, 2026 -9.36%
Dec 31, 2025 4.67%
Sep 30, 2025 -16.67%
Jun 30, 2025 -14.71%
Mar 31, 2025 -22.14%
Dec 31, 2024 -2.93%
Sep 30, 2024 -25.33%
Jun 30, 2024 -11.51%
Mar 31, 2024 -15.04%
Dec 31, 2023 -14.16%
Sep 30, 2023 -26.87%
Jun 30, 2023 -30.64%
Mar 31, 2023 -28.86%
Dec 31, 2022 -24.37%
Sep 30, 2022 -52.80%
Jun 30, 2022 -57.44%
Mar 31, 2022 -45.56%
Dec 31, 2021 -52.02%
Sep 30, 2021 -71.63%
Jun 30, 2021 -58.60%